grand rounds - optimizing lung health in cystic fibrosis
Wednesday, September 05, 2018 | 8:30 a.m. - 9:30 a.m.
optimizing lung health in cystic fibrosis
Jamshed Kanga, MD- Professor of Pediatrics; Chief, Division of Pediatric Pulmonology, Director, Cystic Fibrosis Center, University of Kentucky Medical Center, Lexington, Kentucky
- Describe the dynamic state of the airway microbiology in cystic fibrosis (CF), changes in prevalence over time, and microbiome diversity.
- Describe the impact of various pathogens on lung function and mortality, associated changes in the microbiome, and the relevance of antimicrobial resistance in the CF population.
- Discuss infection management beginning with prevention and control measures, followed by eradication protocols, chronic suppressive therapy, and management of pulmonary exacerbations.